Scientists and doctors around the world are working together in new ways to improve how lung diseases are prevented, diagnosed and treated. Recently, the American Lung Association supported two international meetings that brought experts together to share ideas, research and new technology that could help people live longer, healthier lives.
New Imaging Technology Could Catch Lung Disease Sooner
At the 22nd Quantitative Imaging Workshop (QIW), which was hosted at the Lung Association headquarters in Chicago with a virtual component on November 12-13, leading experts from around the world explored how advances in imaging tools can provide a clearer picture of what's happening inside the lungs. These tools could help doctors spot signs of lung disease years before symptoms appear, when the disease is most treatable.
According to James L. Mulshine, MD, an oncologist, professor of internal medicine at Rush University and one of the co-founders of QIW, imaging technology has improved dramatically over the past two decades. “Imaging has gotten better and safer,” Dr. Mulshine said. “We’re using some of the best imaging tools available to mankind. With new sensors and technology, you can start looking at these early events in the lungs that have been invisible up until now.”
Dr. Mulshine calls these advancements “disrupters” in how we think about diseases of the chest. With millions of people being screened, sometimes every year, “we’re going to learn a tremendous amount about these diseases,” Dr. Mulshine continued. "We have to put together foundations so we can systematically pull and share this information.”
Why does that matter to patients? The earlier providers find a potential problem, the more options people may have to monitor their health and make informed decisions about treatment. This includes the ability to find rapidly growing processes, such as small cell lung cancer. In some cases, researchers believe they may be able to identify disease development three to five years before medical intervention is needed.
Why Collaboration Matters
After serving on the National Institutes of Health (NIH) faculty for more than 20 years, Dr. Mulshine said the experience showed hm first-hand the value of true collaboration, which included shared acceptance and respect for all professional experiences and input.
As doctors learn more from imaging scans, specialists from different fields may be able to work together more effectively. For instance, a heart specialist reviewing a scan might notice changes in the lungs, while a lung doctor could identify concerns related to the heart. This type of collaboration could help patients receive more complete care. “We need to make sure that care is integrated so we’re doing the best we can for each person,” Dr. Mulshine continued. “Heart disease, lung cancer and lung disease are the leading causes of premature death. This is about integrating care across all three. The American Lung Association understands this.”
COPD-iNET: A Push to Improve COPD Care
Global collaboration was also the focus of the 2026 Pittsburgh International Lung Conference, in collaboration with COPD-iNET. Nearly 230 researchers, clinicians and health leaders gathered to discuss new approaches to understanding and treating chronic obstructive lung disease, or COPD.
COPD affects more than 16 million people in the United States. The condition prevents airflow to the lungs, causes breathing problems and diminishes life quality. While there is no cure, medications, supplemental oxygen and lifestyle changes can help people manage risks and reduce flare-ups, which can help prevent emergency department visits, hospitalizations and long-term decline in lung function.
"Today, COPD is considered an incurable disease," said Enid Neptune, MD, co-chair of this year’s COPD-iNET conference. "The way it can be cured (in the future) is with focus, intention and by creating this larger community of researchers and clinicians."
COPD-iNET was created to build a stronger team of researchers and speed up the process of turning scientific discoveries into real treatments for patients. “There was an awareness that for COPD research to move forward, a greater sense of community was needed,” said Dr. Neptune, an academic pulmonologist and lung biologist at Johns Hopkins University and Lung Association Scientific Advisory Committee member.
Researchers affiliated with COPD-iNET are working toward a bigger goal: finding ways to prevent, better treat and eventually cure COPD. "We're all working toward the same goals: better prevention, earlier diagnosis, improved treatment and ultimately a cure for COPD," said Lung Association President and CEO Harold Wimmer who was also in attendance.
Building a Worldwide Research Network
Researchers say one of the biggest benefits of these meetings is the opportunity to connect with colleagues from around the world. By combining data, sharing resources and studying diverse patient populations, scientists can gain a deeper understanding of how lung diseases develop and affect different communities.
This growing network of researchers is helping move discoveries from the laboratory into real-world care faster than ever before. For patients and families affected by lung disease, these efforts offer hope that future care will be more personalized, effective and proactive.
Learn more about how our American Lung Association Research Institute supports vast lung disease research initiatives.
Blog last updated: November 19, 2026
